Camad, Nadzman .
HRN: 21-88-08 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2022
CEFUROXIME 1.5GM (VIAL)
09/06/2022
09/13/2022
IV
1.5gm
Q8hrs
PROM
Waiting Final Action
09/06/2022
CEFUROXIME 1.5GM (VIAL)
09/06/2022
09/12/2022
IV
1.5 Grams
Q8
S/P CS
Waiting Final Action
09/07/2022
CEFUROXIME 500MG (TAB)
09/07/2022
09/14/2022
PO
500 Mg
Q12H
UTI
Waiting Final Action